Search by Drug Name or NDC

    NDC 70954-0202-20 Digoxin 0.25 mg/1 Details

    Digoxin 0.25 mg/1

    Digoxin is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novitium Pharma LLC. The primary component is DIGOXIN.

    Product Information

    NDC 70954-0202
    Product ID 70954-202_0e300c02-ed73-4354-9a77-e29d2e6d93b4
    Associated GPIs 31200010000310
    GCN Sequence Number 000019
    GCN Sequence Number Description digoxin TABLET 250 MCG ORAL
    HIC3 A1A
    HIC3 Description DIGITALIS GLYCOSIDES
    GCN 00133
    HICL Sequence Number 000004
    HICL Sequence Number Description DIGOXIN
    Brand/Generic Generic
    Proprietary Name Digoxin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Digoxin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 0.25
    Active Ingredient Units mg/1
    Substance Name DIGOXIN
    Labeler Name Novitium Pharma LLC
    Pharmaceutical Class Cardiac Glycoside [EPC], Cardiac Glycosides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215307
    Listing Certified Through 2024-12-31

    Package

    NDC 70954-0202-20 (70954020220)

    NDC Package Code 70954-202-20
    Billing NDC 70954020220
    Package 1000 TABLET in 1 BOTTLE (70954-202-20)
    Marketing Start Date 2021-11-22
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.20107
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description DIGOXIN 250 MCG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL dba3b3f7-3ff2-4996-8653-b0e54a398bf9 Details

    Revised: 8/2022